Nais Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Far Rockaway, NY and active since 2007.
Nais Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Evans Scharf at the company’s single location by writing to 1010 Moss Place, Far Rockaway, New York NY 11691 or by phoning (516) 837-6232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nais Pharmaceuticals Inc |
| Contact Person: | Evans Scharf |
| Address: | 1010 Moss Place, Far Rockaway, New York 11691 |
| Phone Number: | (516) 837-6232 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Nais Pharmaceuticals Inc was started in 2007 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Evans Scharf for inquiries that concern Nais Pharmaceuticals Inc by calling the company number (516) 837-6232, as your correspondence is most welcome. Additionally, the physical location of the single location of Nais Pharmaceuticals Inc can be found at the coordinates 40.608273,-73.743539 as well as the street address 1010 Moss Place in Far Rockaway, New York 11691.
For its online presence, you may visit Nais Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.